These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7881194)

  • 41. Optimal control for a cancer chemotherapy problem with general growth and loss functions.
    Murray JM
    Math Biosci; 1990 Mar; 98(2):273-87. PubMed ID: 2134507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of cell kinetics in cancer chemotherapy.
    Valeriote FA; Edelstein MB
    Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554
    [No Abstract]   [Full Text] [Related]  

  • 43. Rapid determination of cellular resistance-related drug efflux in tumor cells.
    Krishan A
    Methods Cell Biol; 1994; 42 Pt B():21-30. PubMed ID: 7877502
    [No Abstract]   [Full Text] [Related]  

  • 44. A qualitative approach to cell growth modeling and simulation for cancer chemotherapy.
    Gaglio S; Giacomini M; Nicolini C; Ruggiero C
    IEEE Trans Biomed Eng; 1991 Apr; 38(4):386-9. PubMed ID: 1855803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth kinetics of solid tumors. Implications for chemotherapy.
    Rosenoer VM; Curby WA
    Med Clin North Am; 1975 Mar; 59(2):339-46. PubMed ID: 1117769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
    Ribeiro D; Pinto JM
    Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New thoughts on resistance to chemotherapy.
    Goldie JH
    Hosp Pract (Off Ed); 1983 May; 18(5):165-9, 173-7. PubMed ID: 6404792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Some optimal control problems in cancer chemotherapy with a toxicity limit.
    Murray JM
    Math Biosci; 1990 Jun; 100(1):49-67. PubMed ID: 2134468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of minimal residual disease.
    Salmon SE
    Recent Results Cancer Res; 1979; 67():1-15. PubMed ID: 451317
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanisms of tumor cell resistance to cancer chemotherapeutic drugs.
    Hansson J
    Eur J Surg Suppl; 1991 May; (561):35-44. PubMed ID: 1720047
    [No Abstract]   [Full Text] [Related]  

  • 52. Factors affecting the development of permanent drug resistance and its impact upon neoadjuvant chemotherapy.
    Coldman AJ; Goldie JH
    Recent Results Cancer Res; 1986; 103():69-78. PubMed ID: 3738197
    [No Abstract]   [Full Text] [Related]  

  • 53. Concepts for the treatment of tumor metastasis.
    Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR
    Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515
    [No Abstract]   [Full Text] [Related]  

  • 54. Are cell kinetic data relevant for the design of tumour chemotherapy schedules?
    van Putten LM
    Cell Tissue Kinet; 1974 Sep; 7(5):493-504. PubMed ID: 4607700
    [No Abstract]   [Full Text] [Related]  

  • 55. The genetic basis of resistance to cancer chemotherapy.
    Woodhouse JR; Ferry DR
    Ann Med; 1995 Apr; 27(2):157-67. PubMed ID: 7632408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
    Boldrini JL; Costa MI
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidrug resistance and behavioural phenotype of cancer cells.
    Bashir I; Sikora K; Foster CS
    Cell Biol Int; 1993 Oct; 17(10):907-17. PubMed ID: 8287021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Principles of chemotherapy of neoplastic diseases in children].
    Matysiak M; Ochocka M
    Pediatr Pol; 1982 Dec; 57(12):1099-105. PubMed ID: 7182789
    [No Abstract]   [Full Text] [Related]  

  • 59. Computer models of anticancer drug interaction.
    Jackson RC; Harrap KR
    Pharmacol Ther; 1979; 4(2):245-80. PubMed ID: 386382
    [No Abstract]   [Full Text] [Related]  

  • 60. Growth of necrotic tumors in the presence and absence of inhibitors.
    Byrne HM; Chaplin MA
    Math Biosci; 1996 Jul; 135(2):187-216. PubMed ID: 8768220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.